The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
Saved in:
| Title: | The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Rejeski K; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. kai.rejeski@med.uni-muenchen.de.; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. kai.rejeski@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. kai.rejeski@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany. kai.rejeski@med.uni-muenchen.de., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Bansal R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sesques P; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France., Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA., Logue JM; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Bräunlein E; IIIrd Medical Department, Klinikum rechts der Isar and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany., Cordas Dos Santos DM; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Theurich S; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany., Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Krackhardt AM; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany.; IIIrd Medical Department, Klinikum rechts der Isar and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.; Department of Medicine I, Malteser Hospital St. Franziskus Hospital, Flensburg, Germany., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Bachy E; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France., Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Subklewe M; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2023 Jul 31; Vol. 16 (1), pp. 88. Date of Electronic Publication: 2023 Jul 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37525244 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rejeski+K%22">Rejeski K</searchLink>; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. kai.rejeski@med.uni-muenchen.de.; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. kai.rejeski@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. kai.rejeski@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany. kai.rejeski@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Hansen+DK%22">Hansen DK</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Bansal+R%22">Bansal R</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Sesques+P%22">Sesques P</searchLink>; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Ailawadhi+S%22">Ailawadhi S</searchLink>; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Logue+JM%22">Logue JM</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Bräunlein+E%22">Bräunlein E</searchLink>; IIIrd Medical Department, Klinikum rechts der Isar and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Cordas+Dos+Santos+DM%22">Cordas Dos Santos DM</searchLink>; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Alsina+M%22">Alsina M</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Theurich+S%22">Theurich S</searchLink>; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Krackhardt+AM%22">Krackhardt AM</searchLink>; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany.; IIIrd Medical Department, Klinikum rechts der Isar and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.; Department of Medicine I, Malteser Hospital St. Franziskus Hospital, Flensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Bachy+E%22">Bachy E</searchLink>; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Jain+MD%22">Jain MD</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Subklewe+M%22">Subklewe M</searchLink>; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2023 Jul 31; Vol. 16 (1), pp. 88. <i>Date of Electronic Publication: </i>2023 Jul 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37525244 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13045-023-01465-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 88 Titles: – TitleFull: The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rejeski K – PersonEntity: Name: NameFull: Hansen DK – PersonEntity: Name: NameFull: Bansal R – PersonEntity: Name: NameFull: Sesques P – PersonEntity: Name: NameFull: Ailawadhi S – PersonEntity: Name: NameFull: Logue JM – PersonEntity: Name: NameFull: Bräunlein E – PersonEntity: Name: NameFull: Cordas Dos Santos DM – PersonEntity: Name: NameFull: Freeman CL – PersonEntity: Name: NameFull: Alsina M – PersonEntity: Name: NameFull: Theurich S – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Krackhardt AM – PersonEntity: Name: NameFull: Locke FL – PersonEntity: Name: NameFull: Bachy E – PersonEntity: Name: NameFull: Jain MD – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Subklewe M IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 07 Text: 2023 Jul 31 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1756-8722 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Journal of hematology & oncology Type: main |
| ResultId | 1 |
